Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
APOBEC MUTAGENESIS IN CANCER - Project 3
Yee, D. (PI)
UT HEALTH SCIENCE CENTER SAN ANTONIO, NIH NATIONAL CANCER INSTITUTE
9/19/25 → 8/31/30
Project: Research project
-
APOBEC MUTAGENESIS IN CANCER - Admin
Yee, D. (PI) & Vogel, R. (CoI)
UT HEALTH SCIENCE CENTER SAN ANTONIO, NIH NATIONAL CANCER INSTITUTE
9/19/25 → 8/31/30
Project: Research project
-
Natural Killer Cell-Mediated Targeting of IGF1R and IR-A in Hormone Receptor-Positive Breast Cancer
Sachdev, D. (PI), Kennedy, P. (CoI) & Yee, D. (CoI)
8/1/25 → 7/31/28
Project: Research project
-
Cancer Center Support Grant
Miller, J. S. (PI), Antonarakis, E. (CoI), Beckman, K. B. (CoI), Betts, B. (CoI), Blaes, A. H. (CoI), Eaton, A. (CoI), Ellis, K. M. (CoI), Felices, M. (CoI), Geller, M. A. (CoI), Ghebre, R. G. (CoI), Griffin, T. J. (CoI), Hallstrom, T. C. (CoI), Harki, D. A. (CoI), Hatsukami, D. K. (CoI), Hirsch, B. A. (CoI), Huang, R. S. S. (CoI), Johnson, S. (CoI), Juckett, M. B. (CoI), Lange, C. A. (CoI), Le, C. T. (CoI), Luo, X. (CoI), McKenna, D. H. (CoI), Miller, J. S. (CoI), Moriarity, B. S. (CoI), Muretta, J. M. (CoI), Murray, T. (CoI), Nelson, H. H. (CoI), Ondrey, F. G. (CoI), Patel, M. R. (CoI), Pennell, C. A. (CoI), Petersen, A. J. (CoI), Peterson, L. A. (CoI), Poynter, J. (CoI), Pratt, R. J. (CoI), Sarver, A. L. (CoI), Schendzielos, D. L. (CoI), Schilz, A. (CoI), Schwertfeger, K. (CoI), Seelig, D. (CoI), Shimizu, Y. (CoI), Stepanov, I. (CoI), Temiz, N. A. (CoI), Ventz, S. (CoI), Villalta, P. W. (CoI), Vogel, R. (CoI), Wagner, J. E. (CoI), Wang, J. (CoI), Webber, B. R. (CoI), Weigel, B. J. (CoI), Yamamoto, M. (CoI), Yee, D. (CoI), Zhang, L. (CoI) & Yee, D. (Prior Principal Investigator)
2/1/24 → 1/31/29
Project: Research project
-
Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial
Leon-Ferre, R. A., Dimitroff, K., Yau, C., Giridhar, K. V., Mukhtar, R., Hirst, G., Hylton, N., Perlmutter, J., DeMichele, A., Yee, D., van ’t Veer, L., Rugo, H., Symmans, W. F., Goetz, M. P., Esserman, L. & Boughey, J. C., Dec 2025, In: Breast Cancer Research. 27, 1, 115.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Correction: A roadmap to reduce the incidence and mortality of breast cancer by rethinking our approach to women’s health (Breast Cancer Research and Treatment, (2025), 209, 1, (1-14), 10.1007/s10549-024-07522-4)
Leggat-Barr, K., Yee, D., Duralde, E., Hodge, C., Borges, V., Baxter, M., Valdez, J., Morgan, T., Garber, J. & Esserman, L., Jan 2025, In: Breast Cancer Research and Treatment. 209, 1, p. 207 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY Trial
Hensley, M., Lengfeld, J., Stoesz, S., Edwards, M., Pass, F., Hirst, G. L., Brown-Swigart, L., van ‘t Veer, L., Esserman, L. J., Beckwith, H. & Yee, D., 2025, In: Frontiers in Oncology. 15, 1605120.Research output: Contribution to journal › Article › peer-review
Open Access -
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial
I-SPY2 Investigators, Jun 1 2025, In: JCO Precision Oncology. 9, e2400776.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Pathologic complete response (pCR) rates for patients with HR+/HER2− high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial
Huppert, L. A., Wolf, D., Yau, C., Brown-Swigart, L., Hirst, G. L., Isaacs, C., Pusztai, L., Pohlmann, P. R., DeMichele, A., Shatsky, R., Yee, D., Thomas, A., Nanda, R., Perlmutter, J., Heditsian, D., Hylton, N., Symmans, F., van't Veer, L. J., Esserman, L. & Rugo, H. S., Feb 2025, In: Annals of Oncology. 36, 2, p. 172-184 13 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations
Press/Media
-
Talking with the experts: October is National Breast Cancer Awareness Month
10/2/20
1 item of Media coverage
Press/Media: Expert Comment or Interview
-
Breast cancer screenings during the pandemic
9/28/20
1 item of Media coverage
Press/Media: Expert Comment or Interview
-
Regis, Great Clips want to be industry leaders in reopening process
5/4/20
1 item of Media coverage
Press/Media: Expert Comment or Interview